Abstract:Menaquinone (MQ) is an essential component of the respiratory chains of many pathogenic organisms, including Mycobacterium tuberculosis (Mtb). The first committed step in MQ biosynthesis is catalyzed by 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexadiene-1-carboxylate synthase (MenD), a thiamin diphosphate (ThDP)-dependent enzyme. Catalysis proceeds through two covalent intermediates as the substrates 2-oxoglutarate and isochorismate are successively added to the cofactor before final cleavage of the product. … Show more
“…Although Ec MenD and Mtb MenD share low sequence identity (30 %), some residues that interact with 2 are conserved and are positioned in a similar manner concerning this substrate, namely Ile474, Leu478, Phe475, Arg107, and Gln118. In particular, Arg107 was shown to bind the C1‐carboxyl and C6‐hydroxy groups, and Gln118 the C6‐hydroxy group, as predicted for Ec MenD in our model . Regarding the loop that interacts with the enolpyruvyl moiety, in Mtb MenD the side chain of Arg282 is involved in a bidentate interaction, while this residue is not conserved in Ec MenD.…”
Section: Methodssupporting
confidence: 69%
“…However, as 2 has two carboxylic acid moieties, it is difficult to unequivocally judge which of the carboxylates binds to each Arg residue. Recently, M. tuberculosis MenD ( Mtb MenD) was crystallized with bound 2 . Although Ec MenD and Mtb MenD share low sequence identity (30 %), some residues that interact with 2 are conserved and are positioned in a similar manner concerning this substrate, namely Ile474, Leu478, Phe475, Arg107, and Gln118.…”
Chorismate and isochorismate constitute branch‐point intermediates in the biosynthesis of many aromatic metabolites in microorganisms and plants. To obtain unnatural compounds, we modified the route to menaquinone in
Escherichia coli
. We propose a model for the binding of isochorismate to the active site of MenD ((1
R
,2
S
, 5
S
,6
S
)‐2‐succinyl‐5‐enolpyruvyl‐6‐hydroxycyclohex‐3‐ene‐1‐carboxylate (SEPHCHC) synthase) that explains the outcome of the native reaction with α‐ketoglutarate. We have rationally designed variants of MenD for the conversion of several isochorismate analogues. The double‐variant Asn117Arg–Leu478Thr preferentially converts (5
S
,6
S
)‐5,6‐dihydroxycyclohexa‐1,3‐diene‐1‐carboxylate (2,3‐
trans
‐CHD), the hydrolysis product of isochorismate, with a >70‐fold higher ratio than that for the wild type. The single‐variant Arg107Ile uses (5
S
,6
S
)‐6‐amino‐5‐hydroxycyclohexa‐1,3‐diene‐1‐carboxylate (2,3‐
trans
‐CHA) as substrate with >6‐fold conversion compared to wild‐type MenD. The novel compounds have been made accessible in vivo (up to 5.3 g L
−1
). Unexpectedly, as the identified residues such as Arg107 are highly conserved (>94 %), some of the designed variations can be found in wild‐type SEPHCHC synthases from other bacteria (Arg107Lys, 0.3 %). This raises the question for the possible natural occurrence of as yet unexplored branches of the shikimate pathway.
“…Although Ec MenD and Mtb MenD share low sequence identity (30 %), some residues that interact with 2 are conserved and are positioned in a similar manner concerning this substrate, namely Ile474, Leu478, Phe475, Arg107, and Gln118. In particular, Arg107 was shown to bind the C1‐carboxyl and C6‐hydroxy groups, and Gln118 the C6‐hydroxy group, as predicted for Ec MenD in our model . Regarding the loop that interacts with the enolpyruvyl moiety, in Mtb MenD the side chain of Arg282 is involved in a bidentate interaction, while this residue is not conserved in Ec MenD.…”
Section: Methodssupporting
confidence: 69%
“…However, as 2 has two carboxylic acid moieties, it is difficult to unequivocally judge which of the carboxylates binds to each Arg residue. Recently, M. tuberculosis MenD ( Mtb MenD) was crystallized with bound 2 . Although Ec MenD and Mtb MenD share low sequence identity (30 %), some residues that interact with 2 are conserved and are positioned in a similar manner concerning this substrate, namely Ile474, Leu478, Phe475, Arg107, and Gln118.…”
Chorismate and isochorismate constitute branch‐point intermediates in the biosynthesis of many aromatic metabolites in microorganisms and plants. To obtain unnatural compounds, we modified the route to menaquinone in
Escherichia coli
. We propose a model for the binding of isochorismate to the active site of MenD ((1
R
,2
S
, 5
S
,6
S
)‐2‐succinyl‐5‐enolpyruvyl‐6‐hydroxycyclohex‐3‐ene‐1‐carboxylate (SEPHCHC) synthase) that explains the outcome of the native reaction with α‐ketoglutarate. We have rationally designed variants of MenD for the conversion of several isochorismate analogues. The double‐variant Asn117Arg–Leu478Thr preferentially converts (5
S
,6
S
)‐5,6‐dihydroxycyclohexa‐1,3‐diene‐1‐carboxylate (2,3‐
trans
‐CHD), the hydrolysis product of isochorismate, with a >70‐fold higher ratio than that for the wild type. The single‐variant Arg107Ile uses (5
S
,6
S
)‐6‐amino‐5‐hydroxycyclohexa‐1,3‐diene‐1‐carboxylate (2,3‐
trans
‐CHA) as substrate with >6‐fold conversion compared to wild‐type MenD. The novel compounds have been made accessible in vivo (up to 5.3 g L
−1
). Unexpectedly, as the identified residues such as Arg107 are highly conserved (>94 %), some of the designed variations can be found in wild‐type SEPHCHC synthases from other bacteria (Arg107Lys, 0.3 %). This raises the question for the possible natural occurrence of as yet unexplored branches of the shikimate pathway.
“…The binding site for DHNA (Figure 2A) is essentially the same in all four structures. The DHNA molecule occupies an 'arginine cage' formed by three arginine residues, Arg97, Arg277 and Arg303, arranged such that the side chains of Arg277 and Whether there is any connectivity between the four allosteric DHNA binding sites in the Mtb-MenD tetramer (as there is between the active sites [13]) is unclear.…”
Section: To Further Characterize the Interactions Betweenmentioning
confidence: 99%
“…Like other members of the ThDP-dependent pyruvate oxidase (POX) family, which are dimers or tetramers (comprising two interfacing dimers), MenD is tetrameric, with each monomer comprising three domains [11,12]. Domains I and III have known roles in catalytic function, domain I from one monomer in the dimer pairs with domain III of the other monomer (and vice versa) to form two paired active sites per dimer, with residues from both domains contributing to each active site [13][14][15]. Domain II, however, is much less conserved and does not appear to participate in cofactor or substrate binding [11,15].…”
Section: Introductionmentioning
confidence: 99%
“…We previously determined a series of crystal structures of Mtb-MenD showing each step in the MenD catalytic cycle, as substrates a-ketoglutarate and isochorismate are successively added to the ThDP cofactor before the final product is released [13].…”
Phone: +64 3 3693044 Running title: Allosteric regulation of Mtb-MenD Abstract Menaquinone (Vitamin K2) plays a vital role in energy generation and environmental adaptation in many bacteria, including Mycobacterium tuberculosis (Mtb). Although menaquinone levels are known to be tightly linked to the redox/energy status of the cell, the regulatory mechanisms underpinning this phenomenon are unclear. The first committed step in menaquinone biosynthesis is catalyzed by MenD, a thiamine diphosphate-dependent enzyme comprising three domains. Domains I and III form the MenD active site, but no function has yet been ascribed to domain II. Here we show the last cytosolicmetabolite in the menaquinone biosynthesis pathway (1,4-dihydroxy-2-napthoic acid, DHNA) binds to domain II of Mtb-MenD and inhibits enzyme activity.We identified three arginine residues (Arg97, Arg277 and Arg303) that are important for both enzyme activity and the feedback inhibition by DHNA: Arg277 appears to be particularly important for signal propagation from the allosteric site to the active site. This is the first evidence of feedback regulation of the menaquinone biosynthesis pathway in bacteria, unravelling a protein level regulatory mechanism for control of menaquinone levels within the cell.
The NHC‐catalysed intermolecular Stetter reaction provides direct access to 1,4‐diketones, however current NHC catalysts for this specific transformation remain underdeveloped, significantly limiting the use of this reaction in target‐oriented synthesis. Here we report a novel N‐mesityl thiazolium NHC as a high‐performing catalyst for this reaction, enabling high yields and short reaction times for a range of sterically non‐trivial aliphatic aldehydes reacting with enone substrates. Quantification of the properties of novel and known NHC organocatalysts revealed that both steric and electronic properties play an important role in the success of the new N‐mesityl thiazolium NHC for this reaction. These developments will facilitate wider application of the Stetter reaction as a key carbon‐carbon bond forming reaction for coupling of complex fragments under mild conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.